Dasatinib is a second-generation tyrosine kinase inhibitor (TKI) used to treat Philadelphia chromosome-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). By inhibiting the… Read more



Dasatinib is a second-generation tyrosine kinase inhibitor (TKI) used to treat Philadelphia chromosome-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). By inhibiting the BCR-ABL fusion protein and various Src-family kinases, this medication disrupts signaling pathways that drive uncontrolled cancer cell proliferation. The compounds in this category—including impurities, metabolites, and stable isotope-labelled standards—are essential tools for pharmaceutical laboratories to ensure drug quality and regulatory compliance. These reference standards are used for rigorous impurity profiling, analytical method validation, and routine quality control during batch release testing. Laboratories utilize stable isotope-labelled compounds, such as deuterated analogs, to achieve precise quantification in complex bioanalytical studies and pharmacokinetics. By providing accurate benchmarks for the identification and quantification of process-related impurities and degradation products, these materials support the development of safe, effective treatments in accordance with international pharmacopeial guidelines.